NewsLocal News

Actions

Henry Ford Allegiance Health Acquires Advanced Technology for Cancer Treatment

Halcyon cancer treatment
Posted
and last updated

Henry Ford Allegiance Health is the first hospital in Michigan and one of the first in the United States.to acquire the Halcyon™ system for cancer treatment. The sophisticated technology with CT image-guided radiation therapy increases treatment precision, poses less risk to healthy tissue and significantly reduces treatment time.

Halcyon conforms the radiation beam to the exact size and shape of the tumor for precise targeting. This highly streamlined process allows patients to complete a treatment session in as little as 10 minutes, minimizing the risk of patient movement and increasing both safety and quality.

“The speed and simplicity of Halcyon make it well-suited to handle the majority of cancer cases, including prostate, lung, breast, head and neck, and many other forms of cancer,” said Annette Kretzler, MD, Henry Ford Allegiance Radiation Oncology.

Multiple features of the Halcyon system further ensure patient safety. The patient lies on a wide couch that moves through the machine for simultaneous imaging and treatment. A two-way intercom and a couch-mounted camera create a close connection between patient and therapist, making it easy to monitor activity and communicate throughout the Halcyon treatment session. Touch-guard technology makes it possible to pause treatment or motion if necessary, and automated machine preperformance checks take place daily.

The machine’s smooth and quiet motion, combined with soft ambient lighting, promotes patient comfort and relaxation and makes the cancer treatment experience less intimidating.

Want to see more local news ? Visit the FOX47News Website.

Stay in touch with us anytime, anywhere.

Download our free app for Appleand Android

and

Sign up for newsletters emailed to your inbox.

Select from these options: Breaking News, Severe Weather, School Closings, Daily Headlines and Daily Forecasts.

Follow us on Twitter

Like us on Facebook